Cargando…
Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs
Pancreatic Ductal Adenocarcinoma (PDAC) is a very lethal disease that typically presents at an advanced stage and is non-compliant with most treatments. Recent technologies have helped delineate associated molecular subtypes and genetic variations yielding important insights into the pathophysiology...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544984/ https://www.ncbi.nlm.nih.gov/pubmed/37790705 http://dx.doi.org/10.3389/fgene.2023.1170571 |